Advertisement

Topics

UK reaffirms commitment to ‘a competitive service for clinical trial assessment’ post Brexit

11:49 EDT 15 Aug 2018 | Outsourcing-Pharma

In an update on the implementation of the new Clinical Trials Regulation, the MHRA expresses increased confidence that the UK will exit the EU with a deal â and reaffirms its commitment to align with parts of the legislation âwithin the UKâs control.â

Original Article: UK reaffirms commitment to ‘a competitive service for clinical trial assessment’ post Brexit

NEXT ARTICLE

More From BioPortfolio on "UK reaffirms commitment to ‘a competitive service for clinical trial assessment’ post Brexit"

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topic

Clinical Approvals
Clinical trials are a set of procedures in medical research conducted to allow safety (or more specifically, information about adverse drug reactions and adverse effects of other treatments) and efficacy data to be collected for health interventions (e.g...